<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>大叔快评 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2021-01-08T20:38:52+08:00</updated>
  <subtitle>肿瘤学临床研究及制药企业研发评述</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>乳腺癌辅助治疗对生育力的影响</title>
    <updated>2021-01-08T17:30:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-08:/s/nP4hzC4c7oSqG5SLnum4Lw</id>
    <link href="https://mp.weixin.qq.com/s/nP4hzC4c7oSqG5SLnum4Lw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>晚期NSCLC循环肿瘤DNA脱落量的基因分型差异</title>
    <updated>2021-01-08T17:30:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-08:/s/yt6gq2fCrEuUpQSShXbuRw</id>
    <link href="https://mp.weixin.qq.com/s/yt6gq2fCrEuUpQSShXbuRw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>NEJM：ER阳性、Her2阴性乳腺癌的全身治疗</title>
    <updated>2021-01-06T22:17:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-06:/s/HhvlpTxzRHPGtprug3mq5A</id>
    <link href="https://mp.weixin.qq.com/s/HhvlpTxzRHPGtprug3mq5A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>MM课堂 | 靳凤艳教授：真实世界中初治多发性骨髓瘤患者早期死亡预后因素及预测模型的建立</title>
    <updated>2021-01-06T22:17:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-06:/s/-Os4eDitCQv21x3W5HL1jg</id>
    <link href="https://mp.weixin.qq.com/s/-Os4eDitCQv21x3W5HL1jg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>MA发展趋势您选择见微知著还是视而不见？</title>
    <updated>2021-01-05T18:23:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-05:/s/biBnlxqGU_9G6Tal9I8FMg</id>
    <link href="https://mp.weixin.qq.com/s/biBnlxqGU_9G6Tal9I8FMg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【年度回顾】2020海外会议精彩大集锦</title>
    <updated>2021-01-05T18:23:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-05:/s/-nYOBT6Rr_xjZNPaN5h5sA</id>
    <link href="https://mp.weixin.qq.com/s/-nYOBT6Rr_xjZNPaN5h5sA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>NEJM：第二款mRNA新冠疫苗phase III研究结果</title>
    <updated>2021-01-04T22:33:10+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-04:/s/FCAMoPZjgqtTfEBOmNdTdA</id>
    <link href="https://mp.weixin.qq.com/s/FCAMoPZjgqtTfEBOmNdTdA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>维布妥昔单抗治疗复发原发纵隔B细胞淋巴瘤的2期临床试验结果</title>
    <updated>2021-01-04T22:33:10+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-04:/s/spX1VAoz-ZxG0cYDfCIBtw</id>
    <link href="https://mp.weixin.qq.com/s/spX1VAoz-ZxG0cYDfCIBtw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【ESMO临床实践指南】肿瘤患者肌肉痉挛的诊断和治疗</title>
    <updated>2021-01-04T22:33:10+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-04:/s/BoW9ODkEHfjuyBEXJcOyFA</id>
    <link href="https://mp.weixin.qq.com/s/BoW9ODkEHfjuyBEXJcOyFA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020年NMPA批准新药48款</title>
    <updated>2021-01-01T11:39:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-01:/s/FVEm6wBZXqDvtIuCkvdiTQ</id>
    <link href="https://mp.weixin.qq.com/s/FVEm6wBZXqDvtIuCkvdiTQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>奥希替尼联合Navitoclax的IB期研究结果</title>
    <updated>2021-01-01T11:39:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-01:/s/U4vxUo8funBuYxEhvZDewg</id>
    <link href="https://mp.weixin.qq.com/s/U4vxUo8funBuYxEhvZDewg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国家卫健委:研究者发起的临床研究管理办法</title>
    <updated>2020-12-31T17:27:10+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-31:/s/Ae-31IcmvuCVxvYHLuJlYQ</id>
    <link href="https://mp.weixin.qq.com/s/Ae-31IcmvuCVxvYHLuJlYQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医学策略的几个误区</title>
    <updated>2020-12-30T20:26:23+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-30:/s/kZyM6EkkdcGk7tCZ6s-xbQ</id>
    <link href="https://mp.weixin.qq.com/s/kZyM6EkkdcGk7tCZ6s-xbQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>马军教授：淋巴瘤靶向治疗进展</title>
    <updated>2020-12-30T20:26:23+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-30:/s/QjaR33_10OeYOT9d991SqA</id>
    <link href="https://mp.weixin.qq.com/s/QjaR33_10OeYOT9d991SqA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Lancet Haematol | BV治疗儿童复发难治性HL或ALCL效果显著、且不良反应基本可控</title>
    <updated>2020-12-30T20:26:23+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-30:/s/TWVO2rCyMVATINzMCg9hGg</id>
    <link href="https://mp.weixin.qq.com/s/TWVO2rCyMVATINzMCg9hGg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医保谈判结果公布：这3种血液领域的药进啦！</title>
    <updated>2020-12-30T20:26:23+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-30:/s/oRriZN67AcrGOvIjDJGyAw</id>
    <link href="https://mp.weixin.qq.com/s/oRriZN67AcrGOvIjDJGyAw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>为何外企的PD-1谈不进医保</title>
    <updated>2020-12-28T21:55:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-28:/s/s_YN2I33gVTOmfrRVHEqcQ</id>
    <link href="https://mp.weixin.qq.com/s/s_YN2I33gVTOmfrRVHEqcQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2021年快到了，立个flag吧</title>
    <updated>2020-12-28T00:05:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-28:/s/Vsu4bm9dQWpjWbwbZNxYWw</id>
    <link href="https://mp.weixin.qq.com/s/Vsu4bm9dQWpjWbwbZNxYWw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>血友病A患者根据药代动力学预防治疗的临床观察结果</title>
    <updated>2020-12-24T22:09:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-24:/s/cEdIr8zC98g8vvNmvz8nog</id>
    <link href="https://mp.weixin.qq.com/s/cEdIr8zC98g8vvNmvz8nog" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>波齐替尼Poziotinib谋求上市和新给药剂量方案</title>
    <updated>2020-12-24T22:09:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-24:/s/ZNBGnmbwkYDtwmYxSyNzFw</id>
    <link href="https://mp.weixin.qq.com/s/ZNBGnmbwkYDtwmYxSyNzFw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>